$IBM

IBM Gets Closer to Fault-Tolerant Quantum Computing with New Cryogenic System - TipRanks.com

IBM announced a milestone in quantum computing, connecting and cooling two cryogenic modules to scale quantum computers. The company aims for a 1,000-qubit system by 2027 and a fault-tolerant quantum computer by 2029. IBM shares are slightly down in pre-market trading after a 1.67% gain on Tuesday, closing at $232.67. Analysts give IBM a Moderate Buy consensus with an average price target of $255.78, suggesting 10% upside.

Original reporting
Published Aug 30, 2026, 1:13 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 30, 2026, 1:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefTechnology
Primary signal
$IBM
Neutral
medium confidence
Mentioned
$IBM
Relevance
7/10
AlphAI data visualization · based on tipranks.com
Decision brief

The 30-second read

$IBMNeutralLow
01

Why it matters

The announcement underscores IBM's progress toward a fault‑tolerant quantum computer, supporting its long‑term strategic positioning but offering limited immediate price catalyst.

02

Market read

While the milestone is positive for IBM's quantum ambitions, the near‑term market impact appears muted; investors may adjust long‑term exposure to quantum tech.

03

What to watch

Potential cost overruns and timeline delays could outweigh technical gains.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

IBM reported a new engineering milestone in its quantum computing program, linking two cryogenic modules and targeting 1,000 qubits by 2027, with shares slightly down pre‑market.

Company-level read

Ticker impact

$IBMNeutralMedium confidence
Context

IBM announced successful connection and cooling of two cryogenic quantum modules, a step toward its 1,000‑qubit fault‑tolerant target.

Expected impact

Short‑term modest dip or flat; medium‑term upside if progress continues.

Evidence & confidence

Technical progress is positive but does not immediately change revenue outlook; market reaction modest.

Market effects

Advances may pressure competing quantum players (Google, Microsoft) and boost sector interest.

U.S. tech sector could see slight positive sentiment toward IBM; limited broader impact.

Highlights ongoing global race for fault‑tolerant quantum computers.

Counterpoint

Investors may view the modest pre‑market dip as a sign of over‑hyped expectations and short the stock.

Key entities

  • IBM

    U.S. technology firm developing quantum computers.

  • Nighthawk processor

    Processor to be installed in the new cryogenic modules for testing.

Related articles

$MSFTMed

Sars to pay Microsoft and IBM R2.75-billion in sole-source deals

South African Revenue Service (Sars) awarded Microsoft and IBM contracts worth R2.75 billion for software, hardware, and support services over three years, approved without open tenders. Microsoft's deal is valued at R1.58 billion, while IBM's is R1.17 billion. Sars also deployed AI tools, including Microsoft Copilot, and reported handling millions of digital queries. Sars faces underfunding risks and is exploring alternative funding models for modernization.

$IBMMed

Wall Street analyst sets IBM stock price for 12 months

Truist Securities analyst Arvind Ramnani initiated a 'Hold' rating for IBM (NYSE: IBM) with a 12-month price target of $240, implying a 6.37% upside from its current price of $225.63. The bullish outlook is based on IBM's strong positioning in key domains, but risks include operational execution and AI infrastructure adoption timelines. TipRanks reports an average price target of $250.45 from 20 analysts, suggesting an 11% potential uptick.

$IBMMed

IBM and SAP Team Up to Support Cloud ERP Modernization for Mid-Sized Enterprises, Offering End-to-End AI Infrastructure Development

IBM and SAP launched 'IBM Ready for SAP Solutions' to aid mid-sized firms in cloud ERP migration, combining SAP's platform with IBM's consulting. Early adopters reported efficiency gains. IBM aims to capitalize on SAP's 2027 maintenance deadline, despite recent financial struggles. IBM's stock is down 25% YTD, with analysts divided on its outlook.

$IBMHighAI 8/10

Truist starts IBM at Hold, says AI demand timing is the key question

Truist initiated coverage of IBM with a Hold rating and $240 price target, citing long-term potential in enterprise computing but near-term execution risks. IBM's Q2 miss was attributed to timing and budget shifts, leading to a 20% stock drop. Software revenue grew 8%, but deferred contracts impacted guidance. Analysts see upside potential if deferred deals close and software growth improves.